The present invention provides a specific binding molecule that binds to Annexin-1 (Anx-A1) for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD. The invention also provides a pharmaceutical composition comprising a specific binding molecule of the invention for use in the treatment of obsessive compulsive disorder (OCD) or a disease related to OCD.
申请公布号
US2015004164(A1)
申请公布日期
2015.01.01
申请号
US201214365311
申请日期
2012.12.14
申请人
Queen Mary & Westfield College, Univ. of London